Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Suprachoroidal Administration in Subjects With Metastases to the Choroid

NCT: NCT06643884 · RECRUITING

NCT IDNCT06643884

StatusRECRUITING

Start Date2024-12-16

Completion2027-10-31

SponsorAura Biosciences (INDUSTRY)

First posted2024-10-16

Last updated2026-10-08

Brief Summary

The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑